KLONIERUNG VON EINSTRÄNGIGER RNA

European patent · EP3325621 · In force

Register entry

Publication number
EP3325621
Application number
EP16741292
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 15, 2016
Published
May 30, 2018
Granted
Jun 30, 2021
Protection ends at the latest
Jul 14, 2036
Next annual fee due
Jul 31, 2027
IPC classes
C12N 15/10 (2006.01)
C12Q 1/6853 (2018.01)
Priority
EP 15177361 17.07.2015
EP 16164608 11.04.2016
PCT application
PCT/EP2016/066876 15.07.2016
PCT publication
WO2017/013005 26.01.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 2, 2022

    Change

    Published in Swissreg on 02.08.2022

  6. May 11, 2022

    Change

    Published in Swissreg on 11.05.2022

  7. Oct 7, 2021

    Agent entered

    Representative
    Vossius & Partner, Patentanwälte Rechtsanwälte mbB, Hirschgässlein 11, 4051 Basel

    Published in Swissreg on 07.10.2021

  8. Jun 30, 2021

    Granted

    Published in Swissreg on 30.06.2021

Parties

Inventor

AKHTAR, Asifa

79104 Freiburg, DE

ILIK, Tugce Aktas

10963 Berlin, DE

ILIK, Ibrahim Avsar

10963 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.